This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasprowicz, V.
Right arrow Articles by Lauer, G. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kasprowicz, V.
Right arrow Articles by Lauer, G. M.

 Previous Article  |  Next Article 

Journal of Virology, March 2008, p. 3154-3160, Vol. 82, No. 6
0022-538X/08/$08.00+0     doi:10.1128/JVI.02474-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome{triangledown}

Victoria Kasprowicz,1 Julian Schulze zur Wiesch,1,2,10 Thomas Kuntzen,1 Brian E. Nolan,1 Steven Longworth,1 Andrew Berical,1 Jenna Blum,1 Cory McMahon,1 Laura L. Reyor,1 Nahel Elias,1,3,10 William W. Kwok,4 Barbara G. McGovern,5 Gordon Freeman,6 Raymond T. Chung,7,10 Paul Klenerman,8 Lia Lewis-Ximenez,9 Bruce D. Walker,1,10 Todd M. Allen,1 Arthur Y. Kim,1 and Georg M. Lauer1*

Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, 6th Floor, Room 6001, Charlestown, Massachusetts 02129-2000,1 Med. Klinik I, Universität Hamburg, Germany,2 Transplantation Unit, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114,3 Benaroya Research Institute at Virginia Mason, Seattle, Washington,4 Lemuel Shattuck Hospital and Tufts University School of Medicine, Boston, Massachusetts,5 Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115,6 Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114,7 Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, South Parks Road, Oxford OX1 3SY, United Kingdom,8 Departmento de Virologia, Instituto Oswaldo Cruz/Fiocruz, Rio de Janeiro, Brazil,9 Howard Hughes Medical Institute, Chevy Chase, Maryland,10

Received 16 November 2007/ Accepted 13 December 2007

We monitored expression of PD-1 (a mediator of T-cell exhaustion and viral persistence) on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells from blood and liver during acute and chronic infections and after the resolved infection stage. PD-1 expression on HCV-specific T cells was high early in acute infection irrespective of clinical outcome, and most cells continued to express PD-1 in resolved and chronic stages of infection; intrahepatic expression levels were especially high. Our results suggest that an analysis of PD-1 expression alone is not sufficient to predict infection outcome or to determine T-cell functionality in HCV infection.


* Corresponding author. Mailing address: Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, MA 02129. Phone: (617) 724-7515. Fax: (617) 726-5411. E-mail: glauer{at}partners.org

{triangledown} Published ahead of print on 26 December 2007.


Journal of Virology, March 2008, p. 3154-3160, Vol. 82, No. 6
0022-538X/08/$08.00+0     doi:10.1128/JVI.02474-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Henson, S. M., Franzese, O., Macaulay, R., Libri, V., Azevedo, R. I., Kiani-Alikhan, S., Plunkett, F. J., Masters, J. E., Jackson, S., Griffiths, S. J., Pircher, H.-P., Soares, M. V. D., Akbar, A. N. (2009). KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 113: 6619-6628 [Abstract] [Full Text]  
  • Radziewicz, H., Ibegbu, C. C., Hon, H., Osborn, M. K., Obideen, K., Wehbi, M., Freeman, G. J., Lennox, J. L., Workowski, K. A., Hanson, H. L., Grakoui, A. (2008). Impaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection. J. Virol. 82: 9808-9822 [Abstract] [Full Text]  
  • Badr, G., Bedard, N., Abdel-Hakeem, M. S., Trautmann, L., Willems, B., Villeneuve, J.-P., Haddad, E. K., Sekaly, R. P., Bruneau, J., Shoukry, N. H. (2008). Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells. J. Virol. 82: 10017-10031 [Abstract] [Full Text]